 |
MARKETS |
 ALGETA.OL | ALGETA(NO) ISIN:NO0010239437 | Oslo Stock Exchange |
 |
|
|
Fortis Company Summary |
|
|
|
COMPANY DATA |
|
|
|
24 COMPANY PROFILE VIEWS |
|
Diese Seite wurde besucht: (letzten 30 Tagen: 4) (seit Veröffentlichung: 24)
|
|
|
|
|
|
|
|
NEWS  |
 |
Algeta ASA (OSL:ALGETA) Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin For Treating Bone Metastases In Patients With Advanced Prostate Cancer
JAN 14, 2009 18:59 - Article Views: 96
Algeta ASA (OSL:ALGETA) Results highlight the potential of Alpharadin to treat bone metastases in major cancer indications
|
|
|
Algeta ASA (OSL:ALGETA) Algeta's Financial Calendar 2009
DEC 16, 2008 21:19 - Article Views: 154
Algeta ASA (OSL:ALGETA) Oslo, Norway, 16 December 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announces its financial calendar 2009.
|
|
|
Algeta ASA (OSL:ALGETA) Algeta Appoints Andrew Kay As President And Chief Executive Officer
DEC 11, 2008 23:03 - Article Views: 126
Algeta ASA (OSL:ALGETA) Appointment enhances Algeta's commercial capabilities and aims to accelerate further development of Alpharadin in advanced prostate cancer
|
|
|
Algeta ASA (OSL:ALGETA) Algeta To Present At Lazard Capital Markets Fifth Annual Healthcare Conference
NOV 13, 2008 18:31 - Article Views: 109
Algeta ASA (OSL:ALGETA) Oslo, Norway, 13 November 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today announces that Dr. Thomas Ramdahl, President and Chief Executive Officer, will be presenting at the Lazard Capital Markets 5th Annual Healthcare Conference to be held at the St. Regis Hotel, 2 East 55th Street, New York City, from November 18 - 19, 2008.
|
|
|
Algeta ASA (OSL:ALGETA) Algeta Reports Results For The Third Quarter 2008
NOV 5, 2008 16:57 - Article Views: 94
Algeta ASA (OSL:ALGETA) Alpharadin - Phase III ALSYMPCA study in hormone-refractory prostate cancer patients now enrolling
|
|
|
Algeta ASA (OSL:ALGETA) Algeta Schedules Third Quarter 2008 Presentation And Conference Call
NOV 3, 2008 21:09 - Article Views: 86
Algeta ASA (OSL:ALGETA) Oslo, Norway, 3 November 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, will announce its third quarter 2008 results on Wednesday, 5 November 2008. A presentation to investors, analysts and the press will take place in Oslo at 08:15 CET and an international conference call will take place at 14:30 CET (details below). Algeta's President and Chief Executive Officer, Dr. Thomas Ramdahl and Chief Financial Officer, Øystein soug will participate.
|
|
|
Algeta ASA (OSL:ALGETA) Change Of Financial Calendar In Algeta
SEP 19, 2008 17:33 - Article Views: 93
Algeta ASA (OSL:ALGETA) Oslo, Norway, 19 September 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announced today that the third quarter results will be presented on 5 November, not on November 12 as previously announced.
|
|
|
Algeta ASA (OSL:ALGETA) Extraordinary General Meeting Held In Algeta
SEP 16, 2008 15:57 - Article Views: 100
Algeta ASA (OSL:ALGETA) Oslo, Norway, 16 September 2008 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announced today that the extraordinary general meeting in Algeta ASA was held on 15 September, and all items on the agenda were resolved.
|
|
|
Algeta ASA (OSL:ALGETA) - Notice Of Extra Ordinary General Meeting
AUG 28, 2008 18:35 - Article Views: 62
Algeta ASA (OSL:ALGETA) Please find notice of an Extra Ordinary General Meeting in Algeta ASA enclosed.
|
|
|
Algeta ASA (OSL:ALGETA) Algeta Reports Positive Headline Phase II Data On Pain Palliation
with Alpharadin
AUG 28, 2008 15:57 - Article Views: 81
Algeta ASA (OSL:ALGETA) Results further support the clinical profile of this novel anti-cancer agent under development to improve the survival of patients with hormone refractory prostate cancer (HRPC)
|
|
|
|
|
More Articles:
|
|
